ReviewAnnals of gastroenterology
Mesenteric inflammatory myofibroblastic tumors.
Review in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 30 citations in OpenAlex.
- Inflammatory myofibroblastic tumor of the psoas muscle presenting as a retroperitoneal mass: a case report.International journal of surgery case reports · 2026Article
- Mesenteric inflammatory myofibroblastic tumor (IMT), a rare neoplasm in a pediatric patient: imaging findings and literature review.Journal of ultrasound · 2025Review
- Inflammatory myofibroblastic tumor of the lung: a comprehensive narrative review of clinical and therapeutic insights.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2025Review
- Inflammatory myofibroblastic tumors in children: a single-center retrospective study of clinical features, management, and outcomes.Frontiers in pediatrics · 2025Article
- Successful management of an unusual case of pediatric inflammatory myofibroblastic tumor: a case report and literature review.Annals of medicine and surgery (2012) · 2025Article
- A Rare Case of Inflammatory Myofibroblastic Tumor Mimicking Fibrous Adhesions Resulting in Bowel Obstruction.Case reports in surgery · 2024Article
- Mesenteric inflammatory myofibroblastic tumor mimicking acute appendicitis: A case report.Annals of medicine and surgery (2012) · 2022Article
- An extremely rare case of malignant jejunal mesenteric inflammatory myofibroblastic tumor in a 61-year-old male patient: A case report and literature review.Frontiers in medicine · 2022Article
- Inflammatory myofibroblastic tumour causing intestinal obstruction in a patient with neurofibromatosis type 1.Annals of the Royal College of Surgeons of England · 2021Article
- Mesenteric inflammatory myofibroblastic tumor as a rare cause of small intestinal intussusception.Journal of surgical case reports · 2020Article
- Interdigitating dendritic cell sarcoma of the spleen with hepatic failure after chemotherapy: A case report.Medicine · 2019Article
- Ultrasonic Manifestations of Mesenteric Inflammatory Myofibroblastic Tumors in Children.Frontiers in pediatrics · 2019Article
- Myofibroblastic infiltration of the bowel: A case report and literature review.International journal of surgery case reports · 2018Article
- Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center.Journal of pathology and translational medicine · 2017Article
- Interdigitating dendritic cell sarcoma presenting in the sigmoid colon mesentery: A case report and literature review.Medicine · 2017Review
- Fever,Weight Loss and Early Satiety due to Gastric Inflammatory Myofibroblastic Tumor; Case Report and Literature Review.Middle East journal of digestive diseases · 2016Article
- Large Omental Inflammatory Myofibroblastic Tumour with Infiltration of Transverse Colon: A Case Report.Journal of the West African College of SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory myofibroblastic tumors (IMTs), also known as inflammatory pseudotumors and inflammatory fibrosarcomas, are uncommon mesenchymal tumors composed of myofibroblastic spindle cells admixed with lymphocytes, plasma cells and eosinophils. Once thought to be reactive, these lesions are now considered to be neoplastic. These tumors can occur throughout the body, most commonly in the lung, mesentery and omentum. Patients commonly present with painless abdominal mass or with intestinal obstruction. IMTs may be multicentric, have a high local recurrence rate and may metastasize in rare cases. The lesions show wide variability in their histologic features and cellularity, and marked inflammatory infiltration, predominantly of plasmatocytes and lymphocytes, and occasionally neutrophils and eosinophils. Anaplastic lymphoma kinase (ALK) rearrangements and/or ALK1 and p80 immunoreactivity are reported in 33-67% of the tumors. Owing to the rarity of these lesions, there are no specific imaging findings that distinguish IMTs from other mesenteric masses. Complete surgical resection is the treatment of choice. Local recurrence rates are high, and re-excision is the preferred therapy for local recurrences. ALK-positive tumors show good response to ALK inhibitors. Current knowledge and comprehensive review of the available literature on IMTs is herein presented.
Indexed as
Identifiers
25608706PMC4290004W1598846508What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.